Bank of New York Mellon’s Oruka Therapeutics ORKA Stock Holding History
Bought
Maintained
Sold
Other funds holding ORKA
VCM
RCP
Bank of New York Mellon's ORKA Position: Q2 2026 in Review
Bank of New York Mellon increased its Oruka Therapeutics (ORKA) stake by 32% in Q2 2026, buying an estimated $2.26M and bringing the position to 140,870 shares worth $13.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1876.
Bank of New York Mellon first reported a position in ORKA in Q2 2025 and has held it in 5 quarters since. 159 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.
- Bank of New York Mellon held 140,870 shares of Oruka Therapeutics worth $13.4M as of Q2 2026.
- Bank of New York Mellon bought 33,987 Oruka Therapeutics shares in Q2 2026, an estimated $2.26M.
- Oruka Therapeutics made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #1876 holding.
- Bank of New York Mellon first reported a position in Oruka Therapeutics in Q2 2025 and has held it in 5 quarters since.
- 159 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.